Kumar Purnima S, Kan Joseph, Galarraga-Vinueza Maria Elisa, Lin Guo-Hao, Monje Alberto, Tavelli Lorenzo, Stuhr Sandra, Hsu Yung-Ting, Li Junying, Tsigarida Alexandra, Dias Debora, Ganesan SukirthMurthy, Yin Shi, Curtis Don
School of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.
School of Dentistry, Loma Linda University, San Bernadino, California, USA.
Clin Adv Periodontics. 2025 Jun;15(2):93-102. doi: 10.1002/cap.10367. Epub 2025 Jun 9.
A consensus meeting on peri-implant diseases and treatment was initiated by the American Academy of Periodontology (AAP) and the Academy of Osseointegration (AO) with the goal of developing subject- and site-level risk profiles for peri-implant diseases and defects, and risk-informed treatment recommendations. This report summarizes the conclusions of Working Group 1.
Working Group 1 evaluated the risk for peri-implant diseases and defects based on four commissioned systematic reviews, followed by an in-person workshop to discuss the reviews and the inferences.
Several factors emerged as risk markers for peri-implant mucositis, peri-implantitis, as well as for soft and hard tissue discrepancies and defects in the absence of disease.
Patient- and site-level factors can increase the odds of developing peri-implant disease or defects in soft tissue and marginal bone surrounding clinically healthy implants. Risk-informed treatment recommendations were made by the panel of experts.
This consensus estimates risk based on both patient and site-level factors. Consideration must be given to modifiable and non-modifiable risk factors, and treatment modified accordingly. There is a lack of primary research on several topics that were considered by the consensus panel, and several gaps in knowledge still continue to exist.
美国牙周病学会（AAP）和骨结合学会（AO）发起了一次关于种植体周围疾病及治疗的共识会议，目的是制定种植体周围疾病和缺损的个体及部位水平风险概况，以及基于风险的治疗建议。本报告总结了第1工作组的结论。
第1工作组基于四项委托进行的系统评价评估了种植体周围疾病和缺损的风险，随后举办了一次面对面研讨会以讨论这些评价及推论。
有几个因素成为种植体周围黏膜炎、种植体周围炎以及无疾病情况下软组织和硬组织差异及缺损的风险标志物。
个体和部位水平的因素会增加临床上健康种植体周围软组织和边缘骨发生种植体周围疾病或缺损的几率。专家小组提出了基于风险的治疗建议。
这一共识基于个体和部位水平的因素评估风险。必须考虑可改变和不可改变的风险因素，并相应地调整治疗方案。共识小组审议的几个主题缺乏初步研究，并且仍然存在一些知识空白。
